2,289
Views
1
CrossRef citations to date
0
Altmetric
Infectious Diseases

Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria

ORCID Icon, , , , , , , , & show all
Pages 652-662 | Received 10 Nov 2022, Accepted 30 Jan 2023, Published online: 22 Feb 2023

References

  • Asaga Mac P, Airiohuodion PE, Yako AB, et al. The seroprevalence and hidden burden of chikungunya endemicity and malaria Mono- and co-infection in Nigeria. IJERPH. 2022;19(15):8896.
  • Ekong PS, Aworh MK, Grossi-Soyster EN, et al. A retrospective study of the seroprevalence of dengue virus and chikungunya virus exposures in Nigeria, 2010–2018. Pathogens. 2022;11(7):762.
  • Carrillo-Hernández MY, Ruiz-Saenz J, Villamizar LJ, et al. Martínez-Gutierrez MCo-circulation and simultaneous coinfection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border. BMC Infect Dis. 2018;18(1):61.
  • MacNamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg. 1954;48(2):139–145.
  • DuPont-Rouzeyrol M, O'Connor O, Calvez E, et al. Coinfection with zika and dengue viruses in 2 patients, New Caledonia, 2014. Emerg Infect Dis. 2015;21(2):381–382.
  • Valencia BM, Sigera PC, Weeratunga P, et al. Effect of prior zika and dengue virus exposure on the severity of a subsequent dengue infection in adults. Sci Rep. 2022;12(1):17225.
  • Iovine NM, Lednicky J, Cherabuddi K, et al. Coinfection with zika and dengue-2 viruses in a traveler returning from Haiti, 2016: clinical presentation and genetic analysis. Clin Infect Dis. 2017;64(1):72–75.
  • Chaves BA, Orfano AS, Nogueira PM, et al. Coinfection with zika virus (ZIKV) and dengue virus results in preferential ZIKV transmission by vector bite to vertebrate host. J Infect Dis. 2018;218(4):563–571.
  • Badolato-Corrêa J, Sánchez-Arcila JC, Alves de Souza TM, et al. Human T-cell responses to dengue and zika virus infection compared to dengue/zika coinfection. Immun Inflamm Dis. 2018; Jun6(2):194–206.
  • Waggoner JJ, Gresh L, Vargas MJ, et al. Viremia and clinical presentation in nicaraguan patients infected with zika virus, chikungunya virus, and dengue virus. Clin Infect Dis. 2016;63(12):1584–1590.
  • Olawoyin O, Kribs C. Coinfection, altered vector infectivity, and Antibody-Dependent enhancement: the dengue–zika interplay. Bull Math Biol. 2020;82(1):13.
  • Oyero OG, Ayukekbong JA. High dengue NS1 antigenemia in febrile patients in ibadan, Nigeria. Virus Res. 2014;191:59–61.
  • Oladipo EK, Awoyelu EH, Oloke JK. Yellow fever, dengue fever, and West Nile virus circulation in ogbomoso. IJMDC. 2018;2:50–54.
  • Pessôa R, Patriota JV, Lourdes de Souza M D, et al. An investigation into an outbreak of dengue-like illness in Pernambuco, Brazil, revealed a circulation of zika, chikungunya, and dengue virus type 1. Medicine (Baltimore). 2016;95(12):e3201.
  • Nas FS, et al. Seroprevalence of dengue fever among febrile patients attending kura general hospital Kano. Nigeria Mathews J Immunol Allergy. 2020;1(4):10.
  • Emeribe AU, Abdullahi IN, Isong IK, et al. Dengue virus is hyperendemic in Nigeria from 2009 to 2020: a contemporary systematic review. Infect Chemother. 2021; Jun53(2):284–299.
  • Reich NG, Shrestha S, King AA, et al. Interactions between dengue serotypes highlight the epidemiological impact of cross-immunity. J R Soc Interface. 2013;10(86):20130414.
  • World Health Organization (WHO). Dengue and severe dengue fever. 2020. https://www.who.int/newsroom/fact-sheets/detail/dengue-and-severe-dengue
  • Humphrey JM, Cleton NB, Reusken CB, et al. Dengue in the Middle east and North africa: a systematic review. PLoS Negl Trop Dis. 2016;10(12):e0005194.
  • Otu A, Ebenso B, Etokidem A, et al. Dengue fever - an update review and implications for Nigeria, and similar countries. Afr H Sci. 2019;19(2):2000–2007.
  • Amarasinghe A, Kuritsk JN, Letson GW, et al. Dengue virus infection in africa. Emerg Infect Dis. 2011;17(8):1349–1354.
  • Nasir IA, Agbede OO, Dangana A, et al. Dengue virus nonstructural protein-1 expression and associated risk factors among febrile patients attending the university of Abuja teaching hospital, Nigeria. Virus Res. 2017;230:7–12.
  • Liebman KA, Stoddard ST, Morrison AC, et al. Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in iquitos, Peru (1999-2003). PLoS Negl Trop Dis. 2012;6(2):e1472.
  • Hatcher EL, Zhdanov SA, Bao Y, et al. Virus variation resource: improved response to emergent viral outbreaks. Nucleic Acids Res. 2017;45(D1):D482–D490.
  • Mustapha JO, Emeribe AU, Nasir IA. Malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria. HIV AIDS (Auckl). 2017;9:145–151.
  • Shaibu JO, Okwuraiwe AP, Jakkari A, et al. OyefoluSero-molecular prevalence of zika virus among pregnant women attending some public hospitals in Lagos state, Nigeria. EJMED. 2021;3(5):77–82.
  • Mathé P, Egah DZ, Müller JA, et al. Low zika virus seroprevalence among pregnant women in North Central Nigeria, 2016. J Clin Virol. 2018;105:35–40.
  • Oluwole T, Fowotade A, Mirchandani D, et al. Seroprevalence of some arboviruses among pregnant women in ibadan, southwestern, Nigeria. Int J Infect Dis. 2022;116: s130–9712.
  • Kolawole OM, Suleiman MM, Bamidele EP. Molecular epidemiology of zika virus and rubella virus in pregnant women attending sobi specialist hospital ilorin, Nigeria. Int J Res Med Sci. 2020;8(6):2275.
  • Kingsley UB, Tabitha VS, Lohya N, et al. Dengue virus antibodies in patients presenting with pyrexia attending jos university teaching hospital, jos, Nigeria. Saudi J pathol microbiol. 2018. 3:47–55.
  • Sule WF, Fadamita TO, Lawal OA, et al. Probable primary and secondary dengue viral infections and associated host factors among university undergraduates in Osun state, Nigeria. Alexandria J Med. 2019;55(1):25–30.
  • Oladipo EK, Amanetu C, Gbadero TA, et al. Detectable anti-dengue virus IgM antibodies among healthy individuals in ogbomoso, Oyo state, Nigeria. Am J Infect Dis. 2014;10(2):64–67.
  • Otu AA, Udoh UA, Ita OI, et al. Prevalence of zika and malaria in patients with fever in secondary healthcare facilities in southeastern Nigeria. Trop Doct. 2020;50(1):22–30. Jan
  • Estofolete CF, Terzian ACB, Colombo TE, et al. Coinfection between zika and different dengue serotypes during the DENV outbreak in Brazil. J Infect Public Health. 2019;12(2):178–181.
  • Ahmadu Shehu M, Bola Odegbemi O, Igwe C, et al. Prevalence and determinants of dengue virus immunoglobulin among febrile patients attending naval medical center Victoria Island, Lagos state. Global Biosecurity. 2020;3(1):1–11.
  • www.mikrogen.de:https://www.mikrogen.de/produkte/produktuebersicht/testsystem/tropical-fever-igg.html.
  • https://select-statistics.co.uk/calculators/confidence-interval-calculator-population-mean/